title: Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats.
abstract: OBJECTIVE
  The restriction of drug transporting across the blood-brain barrier (BBB) and the limit of drug penetrating into the tumor tissue remain the major obstacles for brain tumor chemotherapy. In the present study, we developed a functionalized liposomal nanoconstruct, epirubicin liposomes modified with tamoxifen (TAM) and transferrin (TF), for transporting drug across the BBB and afterwards targeting the brain glioma.
  
  
  METHODS
  Evaluations were performed on the murine C6 glioma cells, the C6 glioma spheroids, the BBB model in vitro and the brain glioma-bearing rats.
  
  
  RESULTS
  When compared with controls, epirubicin liposomes modified with TAM and TF showed the strongest inhibitory effect to C6 glioma cells or glioma spheroids in vitro, significant transport ability across the BBB model in vitro, an evident effect of targeting the brain tumor cells in vitro, and an extended median survival time in the brain glioma-bearing rats.
  
  
  CONCLUSIONS
  Epirubicin liposomes modified with TAM and TF significantly improve the therapeutic efficacy of brain glioma in vitro and in animals, hence providing a new strategy for brain tumor chemotherapy.
authors.affiliation: State Key Laboratory of Natural and Biomimetic Drugs, and School of Pharmaceutical Sciences, Peking University, Beijing, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Tian
authors.forename: Xue
authors.initials: X
authors.lastname: Ying
authors.forename: Ju
authors.initials: J
authors.lastname: Du
authors.forename: Jia
authors.initials: J
authors.lastname: Guo
authors.forename: Ying
authors.initials: Y
authors.lastname: Men
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhang
authors.forename: Ruo-Jing
authors.initials: RJ
authors.lastname: Li
authors.forename: Hong-Juan
authors.initials: HJ
authors.lastname: Yao
authors.forename: Jin-Ning
authors.initials: JN
authors.lastname: Lou
authors.forename: Liang-Ren
authors.initials: LR
authors.lastname: Zhang
authors.forename: Wan-Liang
authors.initials: WL
authors.lastname: Lu
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy*; D045744:Cell Line, Tumor; D018920:Coculture Techniques; D015251:Epirubicin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005910:Glioma / Q000188:drug therapy*; D008081:Liposomes; D051379:Mice; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000970:Antineoplastic Agents; D008081:Liposomes; D015251:Epirubicin